ZIVO Bioscience, Inc.
Income Statement
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $103.9K | $82.7K |
| Cost of Revenue | — | — | — | $0 | $0 | $138.3K | $51.8K |
| Gross Profit | — | — | — | $0 | $0 | $-34.4K | $30.9K |
| Gross Margin | — | — | — | — | — | -33.1% | 37.4% |
| Operating Expenses | |||||||
| Research & Development | $789.0K | $1.0M | $2.0M | $1.0M | $677.5K | $377.9K | $395.6K |
| SG&A Expense | $832.2K | $963.3K | $1.0M | $1.2M | $938.2K | $603.1K | $1.2M |
| Operating Income | $-3.5M | $-3.1M | $-5.2M | $-3.1M | $-2.1M | $-1.9M | $-4.1M |
| Operating Margin | — | — | — | — | — | -1,865.7% | -4,909.1% |
| Interest Expense | $-35.5K | $-2.4K | $515.6K | $-441.5K | $-141.7K | $-47.1K | $-14.0K |
| Pretax Income | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — |
| Net Income | $-6.1M | $-5.8M | $680.8K | $-10.1M | $-3.2M | $-2.7M | $-7.1M |
| Net Margin | — | — | — | — | — | -2,629.3% | -8,609.8% |
| EPS (Basic) | $-0.05 | $-0.04 | $0.01 | $-0.09 | $-0.03 | $-0.03 | $-0.08 |
| EPS (Diluted) | $-0.05 | $-0.04 | $0.01 | $-0.09 | $-0.03 | $-0.03 | $-0.08 |
| Shares Outstanding (Basic) | 136.7M | 132.2M | 125.3M | 112.2M | 105.3M | 100.0M | 92.7M |
| Shares Outstanding (Diluted) | 136.7M | 132.2M | 125.3M | 112.2M | 105.3M | 100.0M | 92.7M |
| Dividends Per Share | — | — | — | — | — | — | — |